{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:10:33Z","timestamp":1790208633283,"version":"4.1.0"},"reference-count":62,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T00:00:00Z","timestamp":1101945600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uveal melanomas threaten visual loss, enucleation, and death from metastatic disease. Most patients present because of symptoms, but failures of detection and diagnosis still occur commonly. Treatments aimed at avoiding enucleation include: plaque, proton beam or stereotactic radiotherapy; trans\u2010scleral or trans\u2010retinal local resection; and transpupillary thermotherapy. Increasingly, different modalities are being used in combination. The ocular outcomes are related to tumour size, location, spread and cell type. Metastatic disease occurs in many patients and is related to factors such as tumour dimensions, ciliary body involvement, cell type, extravascular matrix patterns and cytogenetics. Abnormalities related to chromosomes 3, 6 and 8 are strongly related to tumour behaviour, for the first time enabling survival probability to be estimated with a high degree of reliability in an individual patient. This enables high\u2010risk individuals to be targeted for screening while providing reassurance to those with a minimal chance of developing metastatic disease. Such targeting would allow selection of patients for adjuvant systemic therapy, should a suitable treatment become available, and would also facilitate the evaluation of such treatment by increasing the statistical power of any randomized prospective study. The high mortality in patients with monosomy 3 melanoma suggests that in these patients ocular treatment is only palliative. Cytogenetic studies suggest that some melanomas may never develop any metastatic potential and if these impressions are confirmed by further studies, then in these patients the main priority of treatment would be to conserve vision.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2004.00917.x","type":"journal-article","created":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T10:50:07Z","timestamp":1101984607000},"page":"639-647","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Developments in the management of uveal melanoma"],"prefix":"10.1111","volume":"32","author":[{"given":"Bertil","family":"Damato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,12,2]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"57","volume-title":"Ocular Tumours: Diagnosis and Treatment","author":"Damato B","year":"2000"},{"key":"e_1_2_9_3_2","volume-title":"Atlas of Intraocular Tumors","author":"Shields JA","year":"1999"},{"key":"e_1_2_9_4_2","volume-title":"Uveal Melanoma. A Model for Exploring Fundamental Cancer Biology","author":"Jager MJ","year":"2004"},{"key":"e_1_2_9_5_2","volume-title":"Ocular Oncology","author":"Albert DM","year":"2004"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0026"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601358"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10579"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1475-1313.2001.00595.x"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.3.333"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.07.002"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070110084030"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1992.127"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.021"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1118\/1.596585"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-002-0713-y"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(02)00345-6"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02144128"},{"key":"e_1_2_9_19_2","first-page":"157","article-title":"Transpupillary thermotherapy: results in 50 patients with choroidal melanoma","volume":"116","author":"Oosterhuis JA","year":"1998","journal-title":"Arch Otolaryngol"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.12.033"},{"key":"e_1_2_9_21_2","first-page":"762","volume-title":"Retina","author":"Damato BE","year":"2001"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01240-X"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.3.213"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-002-0647-4"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.62.6.420"},{"key":"e_1_2_9_26_2","first-page":"1168","article-title":"Results from the Collaborative Ocular Melanoma Study (COMS) of enucleation versus preoperative radiation therapy in the management of large ocular melanomas [letter]","volume":"43","author":"Earle JD","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100160707007"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30864-0"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.09.028"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.3.366"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.2.102"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.3.397"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.1.110e"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.05.007"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000425695"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01277-0"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.12.1665"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700639"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0538"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90736-9"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0159"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.0.CO;2-R"},{"key":"e_1_2_9_43_2","first-page":"3032","article-title":"Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway","volume":"59","author":"Parrella P","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11558"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080140101036"},{"key":"e_1_2_9_46_2","first-page":"1414","article-title":"Tumor\u2010infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma","volume":"42","author":"M\u00e4kitie T","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1333"},{"key":"e_1_2_9_48_2","first-page":"2153","article-title":"Association of HLA class I and class II antigen expression and mortality in uveal melanoma","volume":"42","author":"Ericsson C","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_9_49_2","first-page":"2471","article-title":"Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma","volume":"40","author":"M\u00e4kitie T","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.7.939"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.6.811"},{"key":"e_1_2_9_52_2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma III: initial mortality findings. COMS Report No. 18","volume":"119","author":"Diener\u2010West M","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.157.6.1950883"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.0.CO;2-G"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.08.045"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00132-1"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200306000-00013"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001001)89:7<1561::AID-CNCR21>3.0.CO;2-R"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200112000-00006"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600521"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)10161-7"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199912000-00006"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11113"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2004.00917.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2004.00917.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:50:53Z","timestamp":1697237453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2004.00917.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1442-9071.2004.00917.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2004.00917.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"2004-12-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}